iShares Biotechnology ETF (NASDAQ:IBB) Stock Position Increased by SteelPeak Wealth LLC

SteelPeak Wealth LLC raised its position in iShares Biotechnology ETF (NASDAQ:IBB) by 5.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,161 shares of the financial services provider’s stock after purchasing an additional 398 shares during the quarter. SteelPeak Wealth LLC’s holdings in iShares Biotechnology ETF were worth $1,120,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Global Assets Advisory LLC bought a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth about $66,059,000. BNP Paribas Financial Markets raised its holdings in iShares Biotechnology ETF by 25.7% during the first quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock worth $282,038,000 after purchasing an additional 420,053 shares in the last quarter. Gray Foundation bought a new position in iShares Biotechnology ETF during the 4th quarter valued at $17,890,000. Jane Street Group LLC bought a new position in iShares Biotechnology ETF during the 1st quarter valued at $14,386,000. Finally, Miller Investment Management LP increased its position in shares of iShares Biotechnology ETF by 2,394.4% during the 4th quarter. Miller Investment Management LP now owns 90,122 shares of the financial services provider’s stock valued at $12,243,000 after purchasing an additional 86,509 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.5 %

Shares of iShares Biotechnology ETF stock traded up $2.16 during trading on Thursday, hitting $144.95. The stock had a trading volume of 1,014,720 shares, compared to its average volume of 1,595,748. The business has a fifty day moving average of $140.97 and a two-hundred day moving average of $136.70. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $150.17.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.